The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
The detection of α-synuclein (α-syn) in the cerebrospinal fluid (CSF) of patients with synucleinopathy has yielded promising but inconclusive results. The aim of the present study was to determine the diagnostic value of α-syn as a biological marker for Dementia with Lewy bodies (DLB) vs. normal sub...
Saved in:
Main Authors: | Elisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, Kostas Vekrellis |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/bb56ccd77ed743bdac5b93a27a196afd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
by: Niklas K U Koehler, et al.
Published: (2013) -
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
by: Christopher Simon, et al.
Published: (2021) -
Advances in dementia with Lewy bodies
by: Melissa J. Armstrong
Published: (2021) -
Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
by: Onofri E, et al.
Published: (2015) -
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
by: Fereshtehnejad SM, et al.
Published: (2013)